FDA Asks Trade Community for Help to Stop Animal Ivermectin Imports for Human Use
FDA is “asking for the assistance of the import community” to help stop the importation of animal ivermectin for use in the treatment of COVID-19 in humans, according to a CSMS message posted by CBP. “Recent news stories and a Health Alert published by the U.S. Centers for Disease Control and Prevention note that poison control centers across the United States are seeing a sharp spike in reports of people suffering adverse health effects after taking ivermectin intended for animals,” FDA said. “We are asking you to help us educate importers and consumers regarding the health consequences of using animal ivermectin, and to report any suspicious attempt to import Ivermectin/Stromectol to FDA-COVID-19-Fraudulent-Products@fda.hhs.gov.”
Sign up for a free preview to unlock the rest of this article
Timely, relevant coverage of court proceedings and agency rulings involving tariffs, classification, valuation, origin and antidumping and countervailing duties. Each day, Trade Law Daily subscribers receive a daily headline email, in-depth PDF edition and access to all relevant documents via our trade law source document library and website.
“FDA has posted numerous articles on FDA.gov warning of the potential adverse health consequences from using animal ivermectin, including the August 30, 2021 letter issued by FDA’s Center for Veterinary Medicine (CVM) “CVM Letter to Veterinarians and Retailers: Help Stop Misuse of Animal Ivermectin to Prevent or Treat COVID-19 in Humans” and a Safety Alert sign for veterinarians and retailers of animal products to use in their businesses,” FDA said. “We encourage you to provide these materials to any of your clients seeking to import animal ivermectin.”